News

FDA is asking manufacturers to immediately stop selling OTC products containing the pain reliever benzocaine (such as Orajel) for teething in infants or children.

While the pharmaceutical industry has made tremendous advances in new drug development this year, FDA has also had to remove drugs from the market or investigate problem drugs. Here are the top 3 drug warnings and problems so far in 2018.

Two studies from the University of Minnesota’s School of Public Health has interesting findings about primary care among low-income patients enrolled in a Medicaid ACO.

Two experts highlight noteworthy updates in the transplant and cellular therapy space. Read more.

The Center for Blood and Cancer Disorders in Fort Worth, Texas, is participating in many value-based contracts. Here’s how it is successful.

A new study explored racial/ethnic differences in healthcare outcomes among patients receiving home healthcare. Here are the shocking results.

Congress recently began hearings on proposals to combat opioid abuse. Our policy analyst weighs in.

Experts say this new migraine medication, the first in 50 years, shows great promise. Here’s what you need to know, including the cost implications

A new survey from Express Scripts has surprisingly findings about medication adherence in patients with chronic diseases.

A new study sheds light on PDMPs and their effectiveness in tackling the opioid crisis and includes one disturbing finding you won’t believe.

Jill Feldstein, MPA, chief operating officer for the Penn Center for Community Health Workers, tells Managed Healthcare Executive how the organization improves population health and provides social support, advocacy, and navigation to high-risk patients.

A new survey by Black Book Research found the top requested services from patients are available through EHRs.

A new study says that physicians and nurses might be overlooking these alerts-a move that risks putting patients in danger.

A new study has shocking results about which commercially available apps improve diabetes-related outcomes.

A new study investigates the impact of interruptions in the emergency room. Here are the disturbing results

A recent survey reveals how hospital technology budgets are changing. Find out if your organization is making similar changes.

The new Bipartisan Budget Act of 2018, to be in effect on January 2019, institutes new reimbursement guidelines for biosimilars under the Medicare coverage gap discount program that remove disincentives for biosimilar uptake and level the playing field for the future market place.

The latest research from PwC’s Health Research Institute has shown that U.S. health leaders are making building a better customer experience for patients a top priority instead of a “nice to have.”

A recent survey has troubling findings regarding health IT executive compensation disparities between genders and races.

A new study has surprising findings about the cost effectiveness of continuous glucose monitoring for type 1 diabetes patients.

Ron Barkley, president of the Cancer Center Business Development Group, which consults with oncology providers on value-based care arrangements, shares tips.

To build trust, health insurers need to demonstrate their value to customers. That means offering a convenient, satisfying customer experience. Here’s how.